Literature DB >> 12610091

Endocervical glandular lesions: controversial aspects and ancillary techniques.

W G McCluggage1.   

Abstract

The incidence of malignant and premalignant endocervical glandular lesions is increasing. This review covers controversial and difficult aspects regarding the categorisation and diagnosis of these lesions. The terminology of premalignant endocervical glandular lesions is discussed because of the differences between the UK terminology and the widely used World Health Organisation classification. The morphology and histological subtypes of premalignant endocervical glandular lesions are described. Early invasive adenocarcinoma and difficulties in the diagnosis and recognition of this entity are covered, as is the measurement of early invasion within cervical adenocarcinoma. Several benign endocervical glandular lesions can mimic malignant and premalignant endocervical glandular lesions, and the distinction of these benign mimics from premalignant and malignant lesions using ancillary immunohistochemical studies is also covered. Antibodies used to distinguish between endometrial and endocervical adenocarcinoma, in the diagnosis of cervical minimal deviation adenocarcinoma of mucinous type (adenoma malignum), and in the diagnosis of cervical mesonephric lesions are also reviewed.

Entities:  

Mesh:

Year:  2003        PMID: 12610091      PMCID: PMC1769901          DOI: 10.1136/jcp.56.3.164

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  79 in total

1.  Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia?

Authors:  J J Park; D Sun; B J Quade; C Flynn; E E Sheets; A Yang; F McKeon; C P Crum
Journal:  Am J Surg Pathol       Date:  2000-10       Impact factor: 6.394

2.  Apoptotic bodies: a consistent morphologic feature of endocervical adenocarcinoma in situ.

Authors:  C V Biscotti; W R Hart
Journal:  Am J Surg Pathol       Date:  1998-04       Impact factor: 6.394

3.  Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.

Authors:  R Klaes; T Friedrich; D Spitkovsky; R Ridder; W Rudy; U Petry; G Dallenbach-Hellweg; D Schmidt; M von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.396

4.  Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings.

Authors:  S A Silver; M Devouassoux-Shisheboran; T P Mezzetti; F A Tavassoli
Journal:  Am J Surg Pathol       Date:  2001-03       Impact factor: 6.394

5.  Early adenocarcinoma of the uterine cervix.

Authors:  T Kaku; T Kamura; K Sakai; S Amada; H Kobayashi; T Shigematsu; T Saito; H Nakano
Journal:  Gynecol Oncol       Date:  1997-05       Impact factor: 5.482

6.  Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.

Authors:  J T Keating; A Cviko; S Riethdorf; L Riethdorf; B J Quade; D Sun; S Duensing; E E Sheets; K Munger; C P Crum
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

7.  Is loop excision adequate primary management of adenocarcinoma in situ of the cervix?

Authors:  S J Houghton; M I Shafi; T P Rollason; D M Luesley
Journal:  Br J Obstet Gynaecol       Date:  1997-03

8.  Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990.

Authors:  G C Alfsen; S O Thoresen; G B Kristensen; E Skovlund; V M Abeler
Journal:  Cancer       Date:  2000-09-15       Impact factor: 6.860

9.  A clinicopathologic study of glandular dysplasia of the cervix.

Authors:  G R Casper; A G Ostör; M A Quinn
Journal:  Gynecol Oncol       Date:  1997-01       Impact factor: 5.482

10.  Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.

Authors:  C Zhou; C B Gilks; M Hayes; P B Clement
Journal:  Am J Surg Pathol       Date:  1998-01       Impact factor: 6.394

View more
  5 in total

Review 1.  [Diagnosis and differential diagnosis of cervical adenocarcinoma].

Authors:  T Löning; L Riethdorf; M Köbel
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

Review 2.  [Categorization of uterine cervix tumors : What's new in the 2014 WHO classification].

Authors:  S F Lax; L-C Horn; T Löning
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

3.  Pattern-based classification of invasive endocervical adenocarcinoma, depth of invasion measurement and distinction from adenocarcinoma in situ: interobserver variation among gynecologic pathologists.

Authors:  Carlos Parra-Herran; Monica Taljaard; Bojana Djordjevic; M Carolina Reyes; Lauren Schwartz; John K Schoolmeester; Ricardo R Lastra; Charles M Quick; Anna Laury; Golnar Rasty; Marisa R Nucci; Brooke E Howitt
Journal:  Mod Pathol       Date:  2016-05-13       Impact factor: 7.842

4.  p16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem.

Authors:  N Murphy; C C B B Heffron; B King; U G Ganuguapati; M Ring; E McGuinness; O Sheils; J J O'Leary
Journal:  Virchows Arch       Date:  2004-09-18       Impact factor: 4.064

5.  Primary endometrioid adenocarcinoma of the cervix with widespread squamous metaplasia--a potential diagnostic pitfall.

Authors:  Lynn Hirschowitz; Chandan Sen; John Murdoch
Journal:  Diagn Pathol       Date:  2007-10-25       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.